查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830868

2025年照護現場血液學診斷全球市場報告

Point Of Care Hematology Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，照護現場，市場規模從2024年的26.6億美元增加至2025年的29億美元，複合年成長率達9.1%。這段歷史時期的成長可歸因於血液疾病盛行率的上升、醫療環境的日益分散、對早期疾病檢測的日益重視、新興市場醫療支出的不斷成長以及攜帶式診斷設備的日益普及。

預計未來幾年照護現場醫療的日益普及、對即時臨床決策的需求不斷成長、家庭醫療診斷的使用日益增多、血液相關疾病的盛行率不斷上升以及預防性醫療保健意識的不斷增強。預測期內的主要趨勢包括血液分析儀的先進連接能力、樣品製備方法的創新、診斷工具中人工智慧的整合、單細胞分析的發展、雲端基礎的數據平台的普及以及實驗室晶片解決方案的進步。

照護現場血液學診斷是指在患者就診時或附近進行的醫學檢測，用於快速評估血液相關疾病，例如貧血、感染疾病和凝血功能障礙。這些檢測能夠快速且準確地提供血液學結果，以支持及時的臨床決策，尤其是在緊急情況和資源有限的環境中。這種方法最大限度地減少了對密集實驗室檢測的依賴，並加快了診斷和治療。

主要的即時血液學診斷類型包括全血球計數 (CBC)、血液凝固檢驗、血紅蛋白檢測和貧血診斷。 CBC 可測量各種血液成分，包括紅血球、白血球、血紅素、血球容積比和血小板，有助於評估整體健康狀況並檢測多種疾病。這些診斷產品以處方箋和非處方兩種形式的耗材和系統形式提供，服務於診斷中心、醫院、血庫、輸血中心和其他醫療機構等最終用戶。

美國關稅的快速上漲以及持續至2025年春季的貿易摩擦，對醫療設備產業產生了重大影響，尤其對進口診斷影像設備零件、手術用不銹鋼和塑膠耗材的影響。醫院和診所抵制漲價，擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要設備重新認證，從而延緩了產品上市時間。企業正在透過雙重採購關鍵零件、擴大國內商品化生產以及加快具成本效益材料的研發來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供照護現場血液學診斷市場統計數據，包括全球市場規模、區域佔有率、照護現場血液學診斷市場佔有率的競爭對手、照護現場血液學診斷細分市場的詳細照護現場、市場趨勢和商業機會，以及您在照護現場血液學診斷行業取得成功所需的數據。本研究報告對即時血液學診斷行業的照護現場和未來趨勢進行了詳細分析，為您提供所需的全面觀點。

血液疾病的日益普及預計將推動照護現場血液學診斷市場大幅成長。血液疾病是指影響紅血球、白血球、血小板和血漿的病理狀況。這些疾病直接影響血液健康，是導致需要定期監測的慢性疾病日益增多的主要原因。即時血液學診斷能夠在患者就診時或附近提供快速且準確的結果，有助於及時發現和管理這些疾病，加速臨床決策速度並改善疾病管理。例如，2024年4月，澳洲非營利組織珀斯血液研究所報告稱，確診患有血友病的患者人數從2021年的233,577人增加到2022年的257,146人。這一趨勢凸顯了照護現場血液學診斷在應對血液疾病日益成長的流行方面將發揮的重要作用。

該市場的主要參與者正在開發先進的解決方案，例如基於試劑盒的人工智慧血液學分析儀，以實現快速且準確的現場血液分析。這些緊湊型設備利用一次性試劑盒和人工智慧演算法，可直接在照護端進行全血細胞計數 (CBC) 和其他分析。例如，2024 年 9 月，美國動物用藥品公司 Zoetis Inc. 推出了 Vetscan OptiCell，這是一款基於試劑盒、支援人工智慧的獸用血液學分析儀。該系統可在幾分鐘內快速提供參考品質的 CBC 結果，同時最大限度地減少維護和手動操作時間。人工智慧影像分析和黏彈性聚焦技術可實現準確的細胞定序、血球分類和自動異常檢測，從而實現可靠且高效的診斷。

2023年6月，美國寵物相關企業, Inc.）收購了赫斯卡（Heska），收購金額未揭露。此次收購擴大了瑪氏的動物診斷業務，並透過利用赫斯卡的照護現場血液學和專業診斷解決方案，鞏固了瑪氏在先進動物醫療保健領域的地位。

照護現場血液學診斷市場由提供快速血液檢測、分散式診斷解決方案和家庭血液監測等服務的營業單位所獲得的收益所構成。市場價值還包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。照護現場血液學診斷市場還包括可攜式血液學分析儀、試劑盒、檢測套組、採血採血針和試劑的銷售。該市場中的商品價值是“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球照護現場血液診斷：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球照護現場血液學診斷市場：成長率分析
  • 全球照護現場血液學診斷市場表現：規模與成長，2019-2024
  • 全球照護現場血液學診斷市場預測：規模與成長，2024-2029 年，2034 年預測
  • 全球照護現場血液學診斷：總潛在市場（TAM）

第6章 市場細分

  • 全球照護現場血液學診斷市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全血球計數
  • 血液凝固檢驗
  • 血紅素檢測
  • 貧血的診斷
  • 其他類型
  • 全球照護現場血液學診斷市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 系統
  • 全球照護現場血液學診斷市場（依處方方法、績效及預測）2019-2024 年、2024-2029 年、2034 年
  • 處方箋產品
  • 非處方藥品
  • 全球照護現場血液學診斷市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 診斷中心
  • 醫院
  • 血庫
  • 輸血中心
  • 其他最終用戶
  • 全球照護現場血液學診斷市場：依血球計數細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 白血球計數
  • 紅血球計數
  • 血小板計數
  • 血球容積比
  • 血紅素濃度
  • 平均紅血球體積（MCV）
  • 全球照護現場血液學診斷市場：按血液凝固檢驗類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 凝血酶原時間（PT）
  • 活化部份凝血活酵素時間（aPTT）
  • 國際標準化比率（INR）
  • D-二聚體檢測
  • 纖維蛋白原水平
  • 全球照護現場血液學診斷市場：依血紅素檢測類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 總血紅素
  • 醣化血紅素（HbA1c）
  • 氧合血紅素
  • 碳氧血紅素
  • 高鐵血紅素
  • 全球照護現場血液學診斷市場：貧血診斷類型細分、績效及預測（2019-2024 年、2024-2029 年預測、2034 年預測）
  • 鐵研究
  • 維生素 B12 水平
  • 葉酸水平
  • 網狀紅血球計數
  • 鐵蛋白檢測
  • 轉鐵蛋白飽和度
  • 全球照護現場血液學診斷市場：按類型細分、實際結果及預測，2019-2024 年、2024-2029 年、2034 年
  • 血型鑑定與交叉配對試驗
  • 紅血球沉積速率
  • 瘧疾原蟲檢測
  • 鐮狀細胞篩檢
  • C反應蛋白檢測

第7章 區域和國家分析

  • 全球照護現場血液學診斷市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球照護現場血液學診斷市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 照護現場血液診斷市場：競爭格局
  • 照護現場血液學診斷市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Sysmex Corporation
  • HORIBA Ltd.
  • Nova Biomedical Corp.
  • SD Sight Diagnostics Ltd.
  • EKF Diagnostics Holdings plc.
  • Medsource Ozone Biomedicals Pvt. Ltd.
  • BioSystems SA
  • Chengdu Seamaty Technology Co. Ltd.
  • Drucker Diagnostics LLC
  • Diamond Diagnostics Inc.
  • DIAGON Kft.
  • BioMedomics Inc.
  • Norma Instruments Zrt.
  • PixCell Medical Technologies Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年照護現場血液學診斷市場：提供新機會的國家
  • 2029 年照護現場血液學診斷市場：細分市場將帶來新機會
  • 2029 年照護現場血液學診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37859

Point-of-care hematology diagnostics refer to medical tests conducted at or near the site of patient care to quickly evaluate blood-related conditions, such as anemia, infections, or clotting disorders. These tests deliver rapid and accurate hematological results to support timely clinical decisions, particularly in emergency or resource-limited settings. This approach minimizes the reliance on centralized laboratory testing and accelerates diagnosis and treatment.

The primary types of point-of-care hematology diagnostics include complete blood count (CBC), coagulation testing, hemoglobin testing, anemia diagnosis, and others. A CBC measures various blood components, including red blood cells, white blood cells, hemoglobin, hematocrit, and platelets, helping to assess overall health and detect a wide range of disorders. These diagnostics are available as consumables and systems and are offered in both prescription-based and over-the-counter formats, serving end users such as diagnostic centers, hospitals, blood banks, transfusion centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The point-of-care hematology diagnostics market research report is one of a series of new reports from The Business Research Company that provides point-of-care hematology diagnostics market statistics, including point-of-care hematology diagnostics industry global market size, regional shares, competitors with a point-of-care hematology diagnostics market share, detailed point-of-care hematology diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care hematology diagnostics industry. This point-of-care hematology diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point of care hematology diagnostics market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth during the historic period can be attributed to the increasing prevalence of hematological disorders, the expansion of decentralized healthcare settings, growing focus on early disease detection, rising healthcare expenditures in emerging markets, and the growing adoption of portable diagnostic devices.

The point of care hematology diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine, rising demand for immediate clinical decision-making, growing use of home healthcare diagnostics, higher prevalence of blood-related disorders, and heightened awareness of preventive healthcare. Key trends expected during the forecast period include advanced connectivity features in hematology analyzers, innovations in sample preparation methods, integration of artificial intelligence in diagnostic tools, developments in single-cell analysis, adoption of cloud-based data platforms, and advancements in lab-on-a-chip solutions.

The increasing prevalence of blood disorders is expected to drive significant growth in the point-of-care hematology diagnostics market. Blood disorders are the conditions affecting red blood cells, white blood cells, platelets, or plasma are rising largely due to the growing incidence of chronic diseases, which directly impact blood health and necessitate regular monitoring. Point-of-care hematology diagnostics facilitate timely detection and management of these disorders by providing rapid, accurate results at or near the patient care site, enabling faster clinical decisions and improved disease management. For example, in April 2024, the Perth Blood Institute, an Australia-based non-profit, reported that the number of individuals diagnosed with hemophilia increased to 257,146 in 2022, up from 233,577 in 2021. This trend underscores the critical role of point-of-care hematology diagnostics in addressing the rising incidence of blood disorders.

Key companies in this market are developing advanced solutions, such as cartridge-based AI-powered hematology analyzers, to deliver rapid and precise on-site blood analysis. These compact devices utilize single-use reagent cartridges and artificial intelligence algorithms to perform complete blood counts (CBC) and other analyses directly at the point of care. For instance, in September 2024, Zoetis Inc., a US-based veterinary health company, launched Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer for veterinary use. This system provides rapid, reference-quality CBC results within minutes, while minimizing maintenance and hands-on time. It features AI-driven image analysis and viscoelastic focusing technology to accurately align cells, classify blood cells, and automatically detect abnormalities, ensuring reliable and efficient diagnostics.

In June 2023, Mars Inc., a US-based pet company, acquired Heska Corporation for an undisclosed amount. This acquisition expands Mars' veterinary diagnostics capabilities and strengthens its position in advanced animal healthcare by leveraging Heska's point-of-care hematology and specialty diagnostic solutions.

Major players in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., Medsource Ozone Biomedicals Pvt. Ltd., BioSystems S.A., Chengdu Seamaty Technology Co. Ltd., Drucker Diagnostics LLC, Diamond Diagnostics Inc., DIAGON Kft., BioMedomics Inc., Norma Instruments Zrt., PixCell Medical Technologies Ltd.

North America was the largest region in the point of care hematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point of care hematology diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point of care hematology diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point of care hematology diagnostics market consists of revenues earned by entities by providing services such as rapid blood testing, decentralized diagnostic solutions, and home-based blood monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care hematology diagnostics market also includes sales of portable hematology analyzers, cartridges and test kits, lancets, and reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care Hematology Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point of care hematology diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care hematology diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care hematology diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Complete Blood Count; Coagulation Testing; Hemoglobin Testing; Anemia Diagnosis; Other Types
  • 2) By Product: Consumables; Systems
  • 3) By Mode Of Prescription: Prescription Based Product; Over-The-Counter Based Product
  • 4) By End User: Diagnostic Centers; Hospitals; Blood Banks; Transfusion Centers; Other End Users
  • Subsegments:
  • 1) By Complete Blood Count: White Blood Cell Count; Red Blood Cell Count; Platelet Count; Hematocrit; Hemoglobin Concentration; Mean Corpuscular Volume (MCV)
  • 2) By Coagulation Testing: Prothrombin Time (PT); Activated Partial Thromboplastin Time (aPTT); International Normalized Ratio (INR); D-Dimer Test; Fibrinogen Level
  • 3) By Hemoglobin Testing: Total Hemoglobin; Glycated Hemoglobin (HbA1c); Oxyhemoglobin; Carboxyhemoglobin; Methemoglobin
  • 4) By Anemia Diagnosis: Iron Studies; Vitamin B12 Levels; Folate Levels; Reticulocyte Count; Ferritin Test; Transferrin Saturation
  • 5) By Other Types: Blood Typing And Crossmatching; Erythrocyte Sedimentation Rate; Malaria Parasite Detection; Sickle Cell Screening; C-Reactive Protein Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Sysmex Corporation; HORIBA Ltd.; Nova Biomedical Corp.; S.D. Sight Diagnostics Ltd.; EKF Diagnostics Holdings plc.; Medsource Ozone Biomedicals Pvt. Ltd.; BioSystems S.A.; Chengdu Seamaty Technology Co. Ltd.; Drucker Diagnostics LLC; Diamond Diagnostics Inc.; DIAGON Kft.; BioMedomics Inc.; Norma Instruments Zrt.; PixCell Medical Technologies Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point Of Care Hematology Diagnostics Market Characteristics

3. Point Of Care Hematology Diagnostics Market Trends And Strategies

4. Point Of Care Hematology Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point Of Care Hematology Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point Of Care Hematology Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point Of Care Hematology Diagnostics Market Growth Rate Analysis
  • 5.4. Global Point Of Care Hematology Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point Of Care Hematology Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point Of Care Hematology Diagnostics Total Addressable Market (TAM)

6. Point Of Care Hematology Diagnostics Market Segmentation

  • 6.1. Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Complete Blood Count
  • Coagulation Testing
  • Hemoglobin Testing
  • Anemia Diagnosis
  • Other Types
  • 6.2. Global Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Systems
  • 6.3. Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prescription Based Product
  • Over-The-Counter Based Product
  • 6.4. Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Centers
  • Hospitals
  • Blood Banks
  • Transfusion Centers
  • Other End Users
  • 6.5. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • White Blood Cell Count
  • Red Blood Cell Count
  • Platelet Count
  • Hematocrit
  • Hemoglobin Concentration
  • Mean Corpuscular Volume (MCV)
  • 6.6. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prothrombin Time (PT)
  • Activated Partial Thromboplastin Time (aPTT)
  • International Normalized Ratio (INR)
  • D-Dimer Test
  • Fibrinogen Level
  • 6.7. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Total Hemoglobin
  • Glycated Hemoglobin (HbA1c)
  • Oxyhemoglobin
  • Carboxyhemoglobin
  • Methemoglobin
  • 6.8. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Iron Studies
  • Vitamin B12 Levels
  • Folate Levels
  • Reticulocyte Count
  • Ferritin Test
  • Transferrin Saturation
  • 6.9. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Typing And Crossmatching
  • Erythrocyte Sedimentation Rate
  • Malaria Parasite Detection
  • Sickle Cell Screening
  • C-reactive Protein Testing

7. Point Of Care Hematology Diagnostics Market Regional And Country Analysis

  • 7.1. Global Point Of Care Hematology Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point Of Care Hematology Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point Of Care Hematology Diagnostics Market

  • 8.1. Asia-Pacific Point Of Care Hematology Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point Of Care Hematology Diagnostics Market

  • 9.1. China Point Of Care Hematology Diagnostics Market Overview
  • 9.2. China Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point Of Care Hematology Diagnostics Market

  • 10.1. India Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point Of Care Hematology Diagnostics Market

  • 11.1. Japan Point Of Care Hematology Diagnostics Market Overview
  • 11.2. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point Of Care Hematology Diagnostics Market

  • 12.1. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point Of Care Hematology Diagnostics Market

  • 13.1. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point Of Care Hematology Diagnostics Market

  • 14.1. South Korea Point Of Care Hematology Diagnostics Market Overview
  • 14.2. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point Of Care Hematology Diagnostics Market

  • 15.1. Western Europe Point Of Care Hematology Diagnostics Market Overview
  • 15.2. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point Of Care Hematology Diagnostics Market

  • 16.1. UK Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point Of Care Hematology Diagnostics Market

  • 17.1. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point Of Care Hematology Diagnostics Market

  • 18.1. France Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point Of Care Hematology Diagnostics Market

  • 19.1. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point Of Care Hematology Diagnostics Market

  • 20.1. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point Of Care Hematology Diagnostics Market

  • 21.1. Eastern Europe Point Of Care Hematology Diagnostics Market Overview
  • 21.2. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point Of Care Hematology Diagnostics Market

  • 22.1. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point Of Care Hematology Diagnostics Market

  • 23.1. North America Point Of Care Hematology Diagnostics Market Overview
  • 23.2. North America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point Of Care Hematology Diagnostics Market

  • 24.1. USA Point Of Care Hematology Diagnostics Market Overview
  • 24.2. USA Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point Of Care Hematology Diagnostics Market

  • 25.1. Canada Point Of Care Hematology Diagnostics Market Overview
  • 25.2. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point Of Care Hematology Diagnostics Market

  • 26.1. South America Point Of Care Hematology Diagnostics Market Overview
  • 26.2. South America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point Of Care Hematology Diagnostics Market

  • 27.1. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point Of Care Hematology Diagnostics Market

  • 28.1. Middle East Point Of Care Hematology Diagnostics Market Overview
  • 28.2. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point Of Care Hematology Diagnostics Market

  • 29.1. Africa Point Of Care Hematology Diagnostics Market Overview
  • 29.2. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point Of Care Hematology Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Point Of Care Hematology Diagnostics Market Competitive Landscape
  • 30.2. Point Of Care Hematology Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Point Of Care Hematology Diagnostics Market Other Major And Innovative Companies

  • 31.1. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.2. Sysmex Corporation
  • 31.3. HORIBA Ltd.
  • 31.4. Nova Biomedical Corp.
  • 31.5. S.D. Sight Diagnostics Ltd.
  • 31.6. EKF Diagnostics Holdings plc.
  • 31.7. Medsource Ozone Biomedicals Pvt. Ltd.
  • 31.8. BioSystems S.A.
  • 31.9. Chengdu Seamaty Technology Co. Ltd.
  • 31.10. Drucker Diagnostics LLC
  • 31.11. Diamond Diagnostics Inc.
  • 31.12. DIAGON Kft.
  • 31.13. BioMedomics Inc.
  • 31.14. Norma Instruments Zrt.
  • 31.15. PixCell Medical Technologies Ltd.

32. Global Point Of Care Hematology Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point Of Care Hematology Diagnostics Market

34. Recent Developments In The Point Of Care Hematology Diagnostics Market

35. Point Of Care Hematology Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Point Of Care Hematology Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point Of Care Hematology Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point Of Care Hematology Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer